Apixaban formulations

Details for Australian Patent Application No. 2011220775 (hide)

Owner Pfizer Inc. Bristol-Myers Squibb Company

Inventors Patel, Jatin; Frost, Charles; Jia, Jingpin; Vema-Varapu, Chandra

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011220775

PCT Pub. Number WO2011/106478

Priority 61/308,056 25.02.10 US

Filing date 24 February 2011

Wipo publication date 1 September 2011

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/437

A61P 7/02 Drugs for disorders of the blood or the extracellular fluid

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/106478 Priority application(s): WO2011/106478

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011220783-Package having an adhesive-based reclosable fastener and methods therefor

2011220771-Reclosable package using low tack adhesive